Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2010
03/10/2010CN101664551A Stabilization of hypoxia inducible factor (HIF) alpha
03/10/2010CN101664414A Combination of brimonidine and timolol for topical ophthalmic use
03/10/2010CN100593401C Combination of an aromatase inhibitor with a bisphosphonate
03/09/2010US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
03/09/2010US7674875 Star polymer such as of a polylactone based on a central phosphorus atom derived from phosphorus oxychloride (POCl3) or ethyl dichlorophosphate; biodegradable and/or biocompatible; sustained release drug delivery; reverse thermal gelation
03/09/2010US7674825 Cardiovascular disorders; stimulant of guanylate cyclase
03/09/2010US7674777 Immunostimulatory nucleic acid molecules
03/09/2010US7674773 Glycosylated derivative of hypolipemic agents; side effect reduction; therapy for insulin resistance; hyperlipidemia agent; impaired lipid metabolism; lowering cholesterol levels
03/09/2010US7674769 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI)
03/09/2010US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution
03/09/2010US7674488 External composition comprising an aqueous extract of red vine leaves and an anti-inflammatory agent
03/09/2010US7674482 for producing acetylcholine and serotonin; improved cognitive function, induced and maintained sleep, reduced pain, inflammation, blood pressure, anxiety, asthma, duration of viral infection, insulin resistance, appetite, and treating depression
03/09/2010US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist
03/09/2010US7674457 treating neurodegenerative disorders by administering a human umbilical cord blood and mannitol blood brain barrier permeabilizer; biodrug treating cerebral ischemia; cells are selected from all different organs
03/09/2010US7674453 Tumor necrosis factor combined with interferon in demyelinating diseases
03/09/2010CA2431952C Muscarinic antagonists
03/09/2010CA2420495C A novel cationic lipopolymer as biocompatible gene delivery agent
03/09/2010CA2411922C Composition for pain mediation and apparatus and method of use thereof
03/09/2010CA2389476C Treatment of dyskinesia with a h3-histamine receptor agonist
03/09/2010CA2382464C High-affinity choline transporter
03/09/2010CA2379282C Amido spiropiperidines promote the release of growth hormone
03/09/2010CA2342960C G protein-coupled receptor antagonists
03/09/2010CA2331726C Modulation of molecular interaction sites on rna and other biomolecules
03/09/2010CA2172153C Regulation of bcl-2 gene expression
03/04/2010WO2010024908A1 Methods for treatment of multiple sclerosis
03/04/2010WO2010024432A1 Therapeutic agent for central nervous system injury
03/04/2010WO2010024384A1 Anti-hepatitis c virus composition
03/04/2010WO2010024110A1 Oxotetrahydrofuran-2-yl-benzimidazole derivative
03/04/2010WO2010023917A1 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
03/04/2010WO2010023858A1 Therapeutic agent for heart failure
03/04/2010WO2010022497A1 Method of treating dysglycemia and glucose excursions
03/04/2010WO2009143078A9 Methods of treating brain cancer using hexose compounds
03/04/2010WO2009137378A3 Sequential administration of chemotherapeutic agents for treatment of cancer
03/04/2010US20100056604 Methods for stimulating nervous system regeneration and repair by inhibiting phosphodiesterase type iv
03/04/2010US20100056486 Combinations comprising antimuscarinic agents and corticosteroids
03/04/2010US20100055789 Method and apparatus for the stimulation of hair growth
03/04/2010US20100055176 Method of Treating Fibromyalgia or Associated Functional Symptoms of Fibromyalgia
03/04/2010US20100055131 Reovirus compositions and methods of use
03/04/2010US20100055080 Bioadhesive directed somatic cell therapy
03/04/2010US20100055074 Light as a Replacement for Mitogenic Factors on Progenitor Cells
03/04/2010DE102008045339A1 Pharmazeutisches Pellet Pharmaceutical pellet
03/04/2010CA2734981A1 Oxotetrahydrofuran-2-yl-benzimidazole derivative
03/03/2010EP2159230A1 Anti-TNF antibodies, compositions, methods and uses
03/03/2010EP2159229A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same
03/03/2010EP2159216A1 Ih - Modulators
03/03/2010EP2158905A2 Composition for the Transdermal Delivery of Fentanyl
03/03/2010EP2158904A2 Composition for the Transdermal Delivery of Fentanyl
03/03/2010EP2158902A1 Ion binding compositions
03/03/2010EP2158895A2 Method for energizing human beings
03/03/2010EP1743648B1 Method for treating inflammation
03/03/2010EP1675465B1 Improved combination bacteriolytic therapy for the treatment of tumors
03/03/2010EP1569656B1 Phosphoantigens for regulating an immune response
03/03/2010EP1505973B1 Combinations for treating multiple myeloma
03/03/2010EP1401421B1 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
03/03/2010EP1286682B1 Methods and compositions for inhibiting immunoglobulin-mediated-reperfusion injury
03/03/2010CN101658675A Pharmaceutical composition containing calcium antagonist, ACE inhibitor and statins
03/03/2010CN101658674A Compound cream containing nanogold crystal negative-ion composite material
03/03/2010CN101658673A Method of treating diabetes
03/02/2010US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents
03/02/2010US7671091 Administering vasodilator in carrier or diluent
03/02/2010US7671070 For therapy of ophthalmic, otic and nasal infections, particularly bacterial infections; conjunctivitis treatment with moxifloxacin hydrochloride
03/02/2010US7671035 Epidermal growth factor receptor antisense oligonucleotides
03/02/2010US7671027 use of agonist of hypothalamic hormone, i.e. GnRH, for preparation to support luteal phase during infertility treatment of female mammals; pharmaceutical agent supports luteal phase after spontaneous ovulation or after stimulation of follicular growth triggering final follicular maturation and ovulation
03/02/2010US7670836 Antimicrobial peptide isolated from Penaeus monodon
03/02/2010US7670791 regulating an alpha 1G T-type calcium channel in the central nervous system and alpha 1H and alpha 1I T-type calcium channels in the peripheral nervous system; analegesic
03/02/2010US7670769 IL1RL-1 as a cardiovascular disease marker and therapeutic target
03/02/2010US7670767 Genetic alterations associated with cancer
03/02/2010US7670620 Topical composition for the treatment of psoriasis and related skin disorders
03/02/2010US7670612 Supplying active materials in various phases in single dosage multicompartment capsule
03/02/2010US7670606 Method for administering a vaginal care composition
03/02/2010US7670601 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders
03/02/2010US7670599 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy
03/02/2010US7670491 Buffered compositions for dialysis
03/02/2010CA2665501A1 Methods and compositions for the treatment and prevention of bone loss
02/2010
02/25/2010WO2010022217A1 Combinations comprising bicyclic s1p lyase inhibitors
02/25/2010WO2010021843A1 Use of antifolates in patients with detectable levels of tff-1 for the cancer treatment
02/25/2010WO2010020970A1 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof
02/25/2010WO2010020969A1 An extended release pharmaceutical composition of entacapone or salts thereof
02/25/2010WO2010020882A1 New combination of active ingredients containing an alpha-1antagonist and a pde 4 inhibitor
02/25/2010WO2010020799A2 Composition
02/25/2010WO2010020609A1 Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies
02/25/2010WO2010020276A1 Treatment of coccidian parasites
02/25/2010WO2010020036A1 Siderophore-mediated iron uptake in bacterial infection
02/25/2010WO2010003037A3 Compositions, systems, and methods for stabilization of a cell and/or macromolecule
02/25/2010WO2010000763A3 Combinations comprising mglur modulators for the treatment of parkinson's disease
02/25/2010WO2009152344A3 Combination therapy using phosphodiesterase inhibitors
02/25/2010WO2009138843A9 Glycosaminoglycan oral use and compositions
02/25/2010WO2009089822A3 Use of an acetylsalicylic acid salt for the treatment of viral infections
02/25/2010WO2009087242A3 Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent
02/25/2010US20100049273 Use of late passage mesenchymal stem cells (mscs) for treatment of cardiac rhythm disorders
02/25/2010US20100048726 Memantine For The Treatment Of Mild And Mild To Moderate Alzheimer's Disease
02/25/2010US20100048654 Use of valsartan or its metabolite to in hibit platelet aggregation
02/25/2010US20100048627 synergistic pharmaceutical combination for the prevention or treatment of diabetes
02/25/2010US20100048616 Combinations comprising antimuscarinic agents and pde4 inhibitors
02/25/2010US20100048615 Combinations comprising antimuscarinic agents and pde4 inhibitors
02/25/2010US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/25/2010US20100048565 Benzimidazole derivatives
02/25/2010US20100048542 Methods and compositions for treating primary and secondary tumors of the central nervous system (cns)
02/25/2010US20100048536 Novel Substituted Diaryl Azepine Derivatives as Integrin Ligands
02/25/2010US20100048522 Ear infections, optionally with antiinflammatory agent
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 1151